Xingyu Du

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 24, 2026
Targeting FUNDC1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Suppressing Mitochondrial Function.

|Jan 22, 2026
Efficacy and safety of induction chemoimmunotherapy in older patients with unresectable stage III NSCLC: a real-world multicenter study.

Xingyu Du, Huan Li, Song Guan

Pageof 1

Frequent Collaborators

1 joint publications

Weinan Yao

1 joint publications

Dong Guo

1 joint publications

Xueyuan Zhang

1 joint publications

Wenbin Shen